ATE138685T1 - Regulierung der zellenproliferation und differenzierung mittels peptiden - Google Patents

Regulierung der zellenproliferation und differenzierung mittels peptiden

Info

Publication number
ATE138685T1
ATE138685T1 AT88909945T AT88909945T ATE138685T1 AT E138685 T1 ATE138685 T1 AT E138685T1 AT 88909945 T AT88909945 T AT 88909945T AT 88909945 T AT88909945 T AT 88909945T AT E138685 T1 ATE138685 T1 AT E138685T1
Authority
AT
Austria
Prior art keywords
differentiation
proliferation
human
peptides
regulation
Prior art date
Application number
AT88909945T
Other languages
English (en)
Inventor
Michael F Holick
Original Assignee
Michael F Holick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael F Holick filed Critical Michael F Holick
Application granted granted Critical
Publication of ATE138685T1 publication Critical patent/ATE138685T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/37—Parathyroid hormone [PTH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88909945T 1987-10-20 1988-10-17 Regulierung der zellenproliferation und differenzierung mittels peptiden ATE138685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11097387A 1987-10-20 1987-10-20

Publications (1)

Publication Number Publication Date
ATE138685T1 true ATE138685T1 (de) 1996-06-15

Family

ID=22335931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909945T ATE138685T1 (de) 1987-10-20 1988-10-17 Regulierung der zellenproliferation und differenzierung mittels peptiden

Country Status (7)

Country Link
EP (1) EP0415924B1 (de)
JP (1) JP2802084B2 (de)
AT (1) ATE138685T1 (de)
AU (1) AU2788089A (de)
CA (1) CA1326460C (de)
DE (1) DE3855331T2 (de)
WO (1) WO1989003873A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
PL341209A1 (en) * 1997-12-18 2001-03-26 Lilly Co Eli Crystalline teriparatide
US20110263509A1 (en) * 2008-10-07 2011-10-27 Haemopep Pharma Gmbh Preparation and use of high-purity hemoparatide (hpth-1-37) for the treatment of inflammatory scaling diseases of the skin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1984260A (en) * 1930-11-10 1934-12-11 Allen & Hanburys Ltd Process for preparing liquids containing active principles or hormones from parathyroid glands
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
EP0293160A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid-Hormon-Antagonisten mit vergrösserten metabolischen Eigenschaften
EP0293158A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten

Also Published As

Publication number Publication date
CA1326460C (en) 1994-01-25
EP0415924A4 (de) 1990-10-18
JP2802084B2 (ja) 1998-09-21
JPH03505517A (ja) 1991-12-05
EP0415924B1 (de) 1996-05-29
WO1989003873A1 (en) 1989-05-05
AU2788089A (en) 1989-05-23
DE3855331D1 (de) 1996-07-04
EP0415924A1 (de) 1991-03-13
DE3855331T2 (de) 1996-10-24

Similar Documents

Publication Publication Date Title
ATE165516T1 (de) Expression von exogenen polynukleotidsequenzen in wirbeltieren
DE69132530D1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
MY102505A (en) Novel osteoinductive factors.
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
DK0489089T3 (da) Terapeutiske peptider
DE69123361D1 (de) Verwendung von interleukin-4 zur behandlung der festen tumoren
ES8507473A1 (es) Un procedimiento para preparar un peptido de resina
ATE138685T1 (de) Regulierung der zellenproliferation und differenzierung mittels peptiden
Tillotson et al. Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells
EP0293471A4 (de) Selbstantigen der primären lebercirrhose.
ZA805505B (en) Methods of using chlamydia vaccine for preventing and treating bovine and ovine diseases
Kato et al. Effect of bone-derived growth factor on DNA, RNA, and proteoglycan synthesis in cultures of rabbit costal chondrocytes
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
ATE94903T1 (de) Analoge des porcin-wachstumshormones.
MXPA02000801A (es) Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.
Statham et al. Protein degradation in duchenne cells in culture
MX9708493A (es) Factor 15 de crecimiento de fibroblastos.
Havemann et al. 437 Modification of tumor proliferation
Gropp et al. 438 High molecular acth-β-lipotropin and calcitonin immunoreactive protein synthesized by lung tumor cells
Luster et al. 439 Biosynthesis of acth, bombesin, calcitonin, neurotensin and substance-p by lung tumor cells of different histological origin
NZ333652A (en) Inhibition of human rotavirus infection using kappa-casein
MX9709217A (es) Factor de crecimiento 13 de fibroblastos.
DE3485883D1 (de) Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge.